DioGenix Raises $1.5M for Clinical Trial of MS Test | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm DioGenix today announced it has raised $1.5 million in a Series B financing round.

Existing investors including life sciences fund Nerveda participated in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.